Insider Trading Alert - BXS, QCOR, PTC, GE And APU Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 27, 2014, 48 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $206.00 to $52,812,000.00.

Highlighted Stocks Traded by Insiders:

BancorpSouth (BXS) - FREE Research Report

Turner Thomas Holmes who is Director at BancorpSouth bought 15,592 shares at $24.43 on Jan. 27, 2014. Following this transaction, the Director owned 15,592 shares meaning that the stake was reduced by 100% with the 15,592-share transaction.

The shares most recently traded at $24.51, up $0.08, or 0.33% since the insider transaction.

The average volume for BancorpSouth has been 729,700 shares per day over the past 30 days. BancorpSouth has a market cap of $2.4 billion and is part of the financial sector and banking industry. Shares are down 3.27% year-to-date as of the close of trading on Monday.

BancorpSouth, Inc. operates as a financial holding company for BancorpSouth Bank that provides commercial banking and financial services to individuals and small-to-medium size businesses. The stock currently has a dividend yield of 0.81%. The company has a P/E ratio of 25.1. Currently there is 1 analyst that rates BancorpSouth a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BXS - FREE

TheStreet Quant Ratings rates BancorpSouth as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full BancorpSouth Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Questcor Pharmaceuticals (QCOR) - FREE Research Report

Broadwood Partners Lp who is Director at Questcor Pharmaceuticals sold 20,000 shares at $65.00 on Jan. 27, 2014. Following this transaction, the Director owned 5.6 million shares meaning that the stake was reduced by 0.36% with the 20,000-share transaction.

The shares most recently traded at $63.78, down $1.22, or 1.91% since the insider transaction. Historical insider transactions for Questcor Pharmaceuticals go as follows:

  • 4-Week # shares sold: 500,000
  • 12-Week # shares sold: 500,000
  • 24-Week # shares bought: 3,250
  • 24-Week # shares sold: 500,000

The average volume for Questcor Pharmaceuticals has been 2.2 million shares per day over the past 30 days. Questcor Pharmaceuticals has a market cap of $3.9 billion and is part of the health care sector and drugs industry. Shares are up 15.74% year-to-date as of the close of trading on Monday.

Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P. The stock currently has a dividend yield of 1.88%. The company has a P/E ratio of 14.7. Currently there are 6 analysts that rate Questcor Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on QCOR - FREE

TheStreet Quant Ratings rates Questcor Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Questcor Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

PTC (PTC) - FREE Research Report

Diouane Marc who is EVP Global Services & Partners at PTC sold 48,163 shares at $35.37 on Jan. 27, 2014. Following this transaction, the EVP Global Services & Partners owned 13,762 shares meaning that the stake was reduced by 77.78% with the 48,163-share transaction.

Ranaldi Robert who is EVP Worldwide Sales at PTC sold 12,500 shares at $35.58 on Jan. 27, 2014. Following this transaction, the EVP Worldwide Sales owned 39,372 shares meaning that the stake was reduced by 24.1% with the 12,500-share transaction.

The shares most recently traded at $35.30, down $0.28, or 0.78% since the insider transaction. Historical insider transactions for PTC go as follows:

  • 4-Week # shares sold: 1,500
  • 12-Week # shares sold: 49,957
  • 24-Week # shares sold: 49,957

The average volume for PTC has been 687,700 shares per day over the past 30 days. PTC has a market cap of $4.3 billion and is part of the technology sector and computer software & services industry. Shares are down 0.25% year-to-date as of the close of trading on Monday.

PTC Inc. develops, markets, and supports software products and solutions in the areas of computer-aided design (CAD), product lifecycle management (PLM), application lifecycle management (ALM), supply chain management (SCM), and service lifecycle management (SLM) worldwide. The company has a P/E ratio of 26.9. Currently there are 2 analysts that rate PTC a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PTC - FREE

TheStreet Quant Ratings rates PTC as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full PTC Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

General Electric (GE) - FREE Research Report

Immelt Jeffrey R who is Chairman and CEO at General Electric bought 40,000 shares at $25.04 on Jan. 27, 2014. Following this transaction, the Chairman and CEO owned 1.9 million shares meaning that the stake was reduced by 2.2% with the 40,000-share transaction.

The shares most recently traded at $25.50, up $0.46, or 1.8% since the insider transaction. Historical insider transactions for General Electric go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 7,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 67,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 67,000

The average volume for General Electric has been 37.9 million shares per day over the past 30 days. General Electric has a market cap of $252.4 billion and is part of the industrial goods sector and industrial industry. Shares are down 10.56% year-to-date as of the close of trading on Monday.

General Electric Company operates as an infrastructure and financial services company worldwide. The stock currently has a dividend yield of 3.53%. The company has a P/E ratio of 15.2. Currently there are 6 analysts that rate General Electric a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GE - FREE

TheStreet Quant Ratings rates General Electric as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share, revenue growth and increase in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full General Electric Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AmeriGas Partners (APU) - FREE Research Report

Energy Transfer Partners, L.P. who is 10% Owner at AmeriGas Partners sold 1.2 million shares at $44.01 on Jan. 27, 2014. Following this transaction, the 10% Owner owned 20.4 million shares meaning that the stake was reduced by 5.56% with the 1.2 million-share transaction.

The shares most recently traded at $42.34, down $1.67, or 3.94% since the insider transaction. Historical insider transactions for AmeriGas Partners go as follows:

  • 12-Week # shares bought: 250
  • 24-Week # shares bought: 7,250

The average volume for AmeriGas Partners has been 334,700 shares per day over the past 30 days. AmeriGas Partners has a market cap of $3.9 billion and is part of the utilities sector and utilities industry. Shares are down 5.54% year-to-date as of the close of trading on Monday.

AmeriGas Partners, L.P. operates as a retail and wholesale distributor of propane gas, and related equipment and supplies in the United States. The stock currently has a dividend yield of 7.93%. The company has a P/E ratio of 19.8. Currently there are 2 analysts that rate AmeriGas Partners a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on APU - FREE

TheStreet Quant Ratings rates AmeriGas Partners as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full AmeriGas Partners Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

Video: How to Select Mutual Funds in Your 401(k)

Video: How to Select Mutual Funds in Your 401(k)